Medifast, Inc. (MED) News
Follow Medifast, Inc. (MED) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Medartis Raises 2026 Growth Forecast on US Performance
Medartis expects organic core revenue growth at constant exchange rates to exceed its previous guidance range and core EBITDA margin to reach the upper end of its “high teens” range. It raised its full-year Touch prosthe
EARNINGS | Nov 02, 2026, 08:02 AM UTC
M
Europris Q3 Sales Miss Estimates on Lower Footfall, Weak Campaigns
Europris said lower footfall and weak campaigns weighed on Q3 sales, which missed estimates.
EARNINGS | Oct 29, 2026, 06:14 AM UTC
M
Navamedic Q3 Revenue Drops on Prescription Drug and Consumer Health Weakness
EQUITY | Oct 29, 2026, 06:13 AM UTC
M
Medifast Reports Q3 2026 Revenue of $72.05 Million, Sets Q4 Guidance
Revenue fell 19.4% year over year but exceeded analyst consensus of $71.3 million. Medifast reported a GAAP loss of $1.57 per share and set Q4 2026 revenue and GAAP EPS guidance midpoints of $65 million and $0.13. Full-y
EQUITY | Oct 27, 2026, 01:04 PM UTC
M
Medifast Reports Q3 Revenue of $72 Million, Guides Q4 EPS
Medifast reported Q3 2026 revenue of $72.0 million, down 19% year over year, and a net loss of $17.5 million, or $1.57 per share. It forecast Q4 2026 revenue of $55 million to $75 million and EPS of $0.00 to $0.25, with
EQUITY | Oct 26, 2026, 12:16 PM UTC
M
Medifast Reports Q3 Net Income of USD -17.511 Million
EARNINGS | Oct 26, 2026, 12:10 PM UTC
M
Medifast Forecasts Q4 Revenue of $55–75 Million
Medifast gave a fourth-quarter revenue outlook of $55–75 million.
EQUITY | Oct 26, 2026, 12:09 PM UTC
L
Medifast Reports Q3 EPS of USD -1.57
EARNINGS | Oct 26, 2026, 12:09 PM UTC
M
Medifast Reports Third-Quarter 2026 Financial Results
Medifast reported results for the quarter ended September 30, 2026. The supplied text contains no financial figures.
EQUITY | Oct 26, 2026, 12:06 PM UTC
M
Medifast to announce third-quarter results
Medifast said it will announce financial results for the quarter ended September 30, 2026.
EQUITY | Oct 14, 2026, 08:06 PM UTC
M
Eni to Sell 10% Stakes in Four PSCs to Medco
Eni will sell 10% interests in the West Ganal, East Ganal, Ganal and Muara Bakau production-sharing contracts to Medco.
MNA | Oct 12, 2026, 05:40 AM UTC
L
Why Weight Loss Plateaus Happen: 5 Metabolic Causes
Baltimore, MD, Sept. 29, 2026 (GLOBE NEWSWIRE) -- A weight loss plateau is one of the most common reasons people abandon a structured weight loss effort altogether. The body stops losing weight when metabolic dysfunction
NEWS | Sep 29, 2026, 11:08 AM UTC
L
Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Sept. 2, 2026 // -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today
EQUITY | Sep 02, 2026, 12:55 PM UTC
L
ICE MED - Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
ICE MED - Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
EQUITY | Sep 02, 2026, 12:55 PM UTC
L
Medifast launches the Medifast Metabolic Health Institute
Medifast announced the launch of the Medifast Metabolic Health Institute.
EQUITY | Aug 27, 2026, 12:30 PM UTC
L
MED - Medifast Announces Second Quarter 2026 Financial Results
MED - Medifast Announces Second Quarter 2026 Financial Results
EARNINGS | Aug 03, 2026, 08:08 PM UTC